Year To Quarter End Statement Of Income

PhoenixBio Co.,Ltd. - Filing #7373608

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Year to quarter end statement of income
Statement of income
Net sales
881,757,000 JPY
1,135,180,000 JPY
Cost of sales
311,040,000 JPY
263,229,000 JPY
Gross profit (loss)
570,716,000 JPY
871,950,000 JPY
Selling, general and administrative expenses
575,801,000 JPY
504,744,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
78,622,000 JPY
70,250,000 JPY
Depreciation
4,111,000 JPY
4,031,000 JPY
Operating profit (loss)
-5,084,000 JPY
367,206,000 JPY
Non-operating income
Interest income
2,743,000 JPY
326,000 JPY
Non-operating income
52,158,000 JPY
38,418,000 JPY
Non-operating expenses
Interest expenses
972,000 JPY
2,120,000 JPY
Non-operating expenses
1,205,000 JPY
2,236,000 JPY
Ordinary profit (loss)
45,868,000 JPY
403,389,000 JPY
Extraordinary income
Extraordinary income
17,285,000 JPY
JPY
Extraordinary losses
Extraordinary losses
JPY
5,000 JPY
Profit (loss) before income taxes
63,154,000 JPY
403,383,000 JPY
Income taxes - current
4,818,000 JPY
46,612,000 JPY
Income taxes - deferred
30,708,000 JPY
-157,000 JPY
Income taxes
35,527,000 JPY
46,454,000 JPY
Profit (loss)
27,626,000 JPY
356,929,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.